Forest plot for the significant MR association between four mediators and anti-H. pylori IgG seropositivity. by Jing Wang (6206297)

Subjects:

Comparison of circulating biomarkers among PHIVAYA subgroups. by Maria Raffaella Petrara (4446358)

Subjects:

Comparison of HIV-DNA and cell-associated HIV-RNA levels among PHIVAYA subgroups. by Maria Raffaella Petrara (4446358)

Subjects:

Flow cytometry gating strategy for (A) total lymphocytes on morphological parameters forward scatter (FSC) and side scatter (SSC); within the lymphocyte gate, selection on FSC-heig... by Maria Raffaella Petrara (4446358)

Subjects:

Schematic representation of the studied populations at the time of study sampling. by Maria Raffaella Petrara (4446358)

Subjects:

Schematic pathogenetic pathway of how persistent HIV reservoir may lead to premature aging and precocious onset of aging-related comorbidities. by Maria Raffaella Petrara (4446358)

Subjects:

Immunological and cellular aging biomarkers of Early Suppressed (ES)- and Late Suppressed (LS)-PHIVAYA. by Maria Raffaella Petrara (4446358)

Subjects:

Comparison of markers of aging among PHIVAYA groups and healthy controls. by Maria Raffaella Petrara (4446358)

Subjects:

Comparison of immune and cellular markers of aging among PHIVAYA subgroups. by Maria Raffaella Petrara (4446358)

Subjects:

Immunological and cellular aging biomarkers in Suppressed (S) and Not Suppressed (NS) PHIVAYA. by Maria Raffaella Petrara (4446358)

Subjects:

Correlation plot between HIV reservoir and immune and cellular markers in PHIVAYA. by Maria Raffaella Petrara (4446358)

Subjects:

Characteristics of the studied populations at the time of study sampling. by Maria Raffaella Petrara (4446358)

Subjects:

Sensitivity and subgroup analysis between higher TV watching time and cognitive scores. by Hattapark Dejakaisaya (22238613)

Subjects:

Sensitivity and subgroup analysis of conventional meta-analysis of TV watching time and risk of cognitive impairment. by Hattapark Dejakaisaya (22238613)

Subjects:

The main characteristics of the 35 studies included in the systematic review categorized by their study designs. by Hattapark Dejakaisaya (22238613)

Subjects:

Effects of GJE extract treatment decreased accumulation of Col1a1. by Natnicha Suttawong (22367172)

DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …”

DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …”

DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …”

DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …”